Publications by authors named "P Bartko"
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) requires advanced techniques and prolonged procedural efforts, often necessitating high contrast volumes, which may increase the risk of contrast-associated acute kidney injury (CA-AKI). However, evidence suggests that factors beyond contrast exposure contribute to CA-AKI, though data specific to CTO PCI remain limited. Patients undergoing contemporary CTO PCI at our university-affiliated tertiary care center were enrolled.
View Article and Find Full Text PDFArticle Synopsis
- - Severe tricuspid regurgitation (TR) is a serious condition linked to high risks of illness and death, particularly in patients with active or multi-organ cancer, delaying necessary treatments.
- - A study at the Medical University of Vienna analyzed outcomes for 973 patients with severe TR, finding that 19% had active or historical cancer, with a notable increase in ten-year mortality among those with active cancers.
- - The research concluded that while severe TR significantly raises mortality rates in those with active cancer, having a history of cancer does not increase mortality compared to patients without cancer; interdisciplinary care is crucial for timely treatment.
Article Synopsis
- This study explores the link between ABO blood groups and the risk of early stent thrombosis in patients who underwent coronary interventions, focusing particularly on non-O blood groups and their association with cardiovascular issues.
- Among 10,714 patients, only 0.73% experienced early stent thrombosis, and while non-O blood groups weren't significantly linked, those with B-antigens (B and AB blood types) showed a higher risk for early thrombosis compared to O type.
- The findings suggest that B-antigen presence is a notable factor in early stent thrombosis risk, indicating a need for more research to understand the biological mechanisms behind this relationship.
Purpose: To evaluate right ventricular (RV) uptake measured by quantitative [Tc]Tc-DPD SPECT/CT to investigate its role in predicting and evaluating prognosis and therapeutic outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CA).
Methods: Patients with ATTR-CA were consecutively enrolled for quantitative [Tc]Tc-DPD SPECT/CT. Ventricular amyloid burden was quantified by SUV and TBR.